Differentiating Your Future Winners

Jay Norman, president of Quintiles Consulting, discusses the changing landscape of drug development and what will differentiate the future winners.

Start your search by selecting a topic or browse content in all topics
Therapeutic Areas Cardiovascular Central Nervous System (CNS) Diabetes/Endocrinology Infectious Diseases Internal Medicine Oncology Pediatrics Women's Health	Business Needs Business transformation Clinical and marketing materials Connect with investigators, regulators and physicians Cost control/reduction Enrollment & retention Faster product development Flexible outsourcing Get to market faster High-quality studies Lower portfolio & investment risks Market analysis Targeted communications Thought leadership	Services Alternative Sales Models Biostatistics Biotech Relationships Central Lab Clinic Profiles Clinical Monitoring Clinical Pharmacology Data Management ECG Global Delivery Go-to-Market Government & Non-Profit Managed Partnerships Market Access Market Intelligence Medical Communications Medical Devices Our Expertise Outsourcing Patient & Investigator Recruitment Patient-centric Services Phase I/IIa Phase II/III Phase IIIB/IV Primary Care Product Development & Commercialization Regulatory Regulatory & Quality Consulting Safety & Risk Management Sales Force Effectiveness Tools Specialty Care Vacancy Management	Locations Africa Asia Australia and New Zealand Europe North and Central America South America

Quintiles